Resilience Mobile App for Teens and Young Adults With Cancer
Part of paid clinical trials in Seattle, Washington.
- Sponsor
- Seattle Children's Hospital
- Study ID
- NCT05842902
- Status
- Recruiting
Conditions
- Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 12 Years - 25 Years
- Healthy Volunteers
- Not accepted
Interventions
- mPRISM — BEHAVIORALPRISM is a brief, 1:1, skills-based resilience intervention delivered in-person by trained layperson coaches. PRISM's development was based on iterative research within the AYA oncology population, stress and coping theory, resilience theory, and successful cognitive-behavioral and mindfulness interventions. mPRISM is a digital version of the PRISM program with no in-person delivery. mPRISM includes coping skills modules: managing stress, goal-setting, cognitive reframing, and meaning-making.
Study Details
The goal of this pilot trial is to examine whether a mobile app version of the Promoting Resilience in Stress Management (PRISM) intervention is acceptable, easy to use, and helps improve quality of life and mental health symptoms.
Key Dates
- Start date
- Sep 12, 2023
- Status verified
- Jul 2025
- Primary completion
- Jun 1, 2027
- Completion
- Jun 1, 2027
Study Design
- Enrollment
- 80 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: mPRISMThe Experimental (mPRISM) arm will receive mPRISM upon completion of their baseline study surveys.
- Other: Waitlist controlUsual Care (UC) available to both study arms consists of standard non-directed supportive care provided for all patients including an assigned social worker throughout cancer treatment. In a waitlist design, the UC arm will receive mPRISM upon completion of 3-month follow-up surveys.
Primary Outcome Measure
Acceptability of intervention [ Time Frame: immediately post-intervention ]
Central Contacts
- Nancy Lau, PhD206-884-0569
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Seattle Children's Hospital | Seattle | Washington | 98105 |
Find similar trials in Seattle, WA
By research site
Related Studies
- Childhood Cancer Survivor StudyRecruiting · St. Jude Children's Research Hospital · Birmingham, Alabama
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama
- A Crowd Sourcing Platform for Patients With CancerRecruiting · All4Cure · Seattle, Washington
- ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid TumorsPHASE1/PHASE2 · Recruiting · Immatics US, Inc. · Stanford, California